Semaglutide or Tirzepatide

GLP-1’s works by increasing insulin production and lowers glucagon production. They mimic the body’s natural GLP-1 hormone, which the gut releases after eating, causing the pancreas to produce more insulin. This helps keep blood sugar levels within a normal range. They also target areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts only minutes.

• Decreased appetite and cravings
• Weight Loss (Works best with a healthy diet and regular exercise)
• Improved blood glucose control

We use a very small needle, most patients do not find it painful.

• Delays how quickly our stomachs digest food, leading to a feeling of fullness and satisfaction with smaller
• meal sizes.
• Slows intestinal motility so you will feel fuller for longer after meals.
• Lowers blood sugars, in part by reducing the production of sugar in the liver.
• Stimulates insulin secretion by the pancreas.

• Most common side effects include nausea and constipation. (We recommend starting MiraLAX with first doses, take every other day for the first 2 weeks)
• Patients have also reported acid reflux, stomach pain, vomiting, and diarrhea
• Serious side effects increase in patients with hypoglycemia, kidney problems, and risk of allergic reactions.
• This medication in NOT insulin and should not be used if you have type 1 diabetes OR if you develop
• diabetic ketoacidosis. This medication should not be used with any other GLP-1 medication.
• Risk of Thyroid C-Cell tumors: If you or any family members have been diagnosed with multiple endocrine neoplasia syndrome Type 2 or Medullary thyroid cancer you should NOT take GLP-1’s If you have ever had pancreatitis consult your primary care doctor prior to starting GLP-1’s because it can increase the risk of developing pancreatitis.
• Warning/Contradiction for Females: There are limited data from the use of GLP-1’s in pregnant women. Therefore, GLP-1’s should not be used during pregnancy or nursing. If a patient wishes to become pregnant, or pregnancy occurs, GLP-1’s should be discontinued.

Semaglutide: Semaglutide is the best option if you are wanting to lose 10-30 pounds, you can lose 15-16% body fat loss.

Tirzepatide: Tirzepatide is a dual action and targets GLP-1 & GIP receptors, it is best if you are needing to lose over 30 pounds, have a sensitivity to Semaglutide, require less gastro side effects, if you hit a plateau on Semaglutide, and for better glycemic control (PCOS, insulin resistant) You can lose 14-18% body fat.